GENZ Biotech; It is an R&D company operating in the field of biotechnology, serving the health of the society, established to make DNA analysis more accessible to the society. As a natural result of the R&D activities we carry out, we are developing gene screening in vitro diagnostic kits that are both efficient and low-cost and most importantly, suitable for the gene pool of the Turkish society. The first product of the GENZ Biotech portfolio, Breast Cancer Risk Panel, was launched at the end of 2018. Our difference is that we develop a DNA screening test that determines general and regional genetic factors based on the Turkish and Middle Eastern society with common genetic heritage. In line with our goal, our work continues with care and at full speed.
Total Funding: $584,616
Funding Stage: Funded
Business Stage: Scaling Up
Market: B2C, B2B
Company Size: 1 to 25
Founded: 2017
For AI Startup Founders
Get introduced to VC/PE/CVC investors
For Investors at VC/PE firms
Get introduced to AI Startup founders or founders at Genz Biotech
Genz Biotech - AI Startup | AI Startup Profile Powered by Appengine AI | Appengine AI - AI Ecosystem of 12,000+ AI Startups
Genz Biotech - Manage Profile
World's Most Promising AI Startups
World's Leading AI Ecosystem of AI Startups, Founders, Investors, and AI Professionals
Get Started